Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2007
Assessment of Chinese-version voice outcome survey in patients with unilateral vocal cord paralysis.
СтатьяВалидационное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Fang Tuan-Jen, Li Hsueh-Yu, Gliklich Richard E, Chen Ya-Hui, Wang Pa-Chun
Аннотация
BACKGROUND: To develop a Mandarin Chinese outcome measure for the assessment of quality of life among unilateral vocal cord paralysis (UVCP) patients.
METHODS: Voice Outcome Survey (VOS) was translated into Mandarin Chinese using a parallel model. The Chinese (Taiwan) version of the VOS (CVOS) was administered to 48 patients with symptomatic UVCP in a prospective manner; the CVOS was validated according to established criteria for reliability, validity, and longitudinal sensitivity.
RESULTS: CVOS demonstrates moderate test-retest reliability (r = 0.59, P < 0.001) and internal consistency (Cronbach's alpha = 0.63). CVOS significantly correlates with most of the subscales in the Mandarin Chinese (Taiwan) version of 36-Item Short-Form Health Survey (SF-36) with only two exceptions (GH, general health; VT, vitality). The standardized response mean for the CVOS total score is 1.91, indicating excellent sensitivity to detect clinical changes.
CONCLUSIONS: Performance characteristics of the CVOS are equivalent to the English-version VOS. CVOS is a valid tool to evaluate adults with UVCP-related problems among Chinese-speaking populations.
METHODS: Voice Outcome Survey (VOS) was translated into Mandarin Chinese using a parallel model. The Chinese (Taiwan) version of the VOS (CVOS) was administered to 48 patients with symptomatic UVCP in a prospective manner; the CVOS was validated according to established criteria for reliability, validity, and longitudinal sensitivity.
RESULTS: CVOS demonstrates moderate test-retest reliability (r = 0.59, P < 0.001) and internal consistency (Cronbach's alpha = 0.63). CVOS significantly correlates with most of the subscales in the Mandarin Chinese (Taiwan) version of 36-Item Short-Form Health Survey (SF-36) with only two exceptions (GH, general health; VT, vitality). The standardized response mean for the CVOS total score is 1.91, indicating excellent sensitivity to detect clinical changes.
CONCLUSIONS: Performance characteristics of the CVOS are equivalent to the English-version VOS. CVOS is a valid tool to evaluate adults with UVCP-related problems among Chinese-speaking populations.